Profile
| Metric | Value |
|---|---|
| Full Name | Sana Biotechnology, Inc. |
| Ticker | NASDAQ: SANA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sana.com |
| Employees | 194 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.73 | |
| Price, 1D Change | +8.49% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 2.03 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$1.16 | |
| EPS, 1Y Change | +20.65% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.16 | |
| EPS Estimate | -$0.73 | |
| EPS Est. Change | +37.10% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $4.73 | |
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +69.13% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.45 | -$1.46 | -0.41% | |
| -$1.10 | -$1.16 | -4.80% | |
| -$0.73 | N/A | +37.10% | |
| -$0.57 | N/A | +51.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +186.67% | |
| Price, 3Y | +30.30% | |
| Market Cap, 1Y | +241.00% | |
| Market Cap, 3Y | +81.70% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | +20.65% | |
| EPS, 3Y | +45.97% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.73 | |
| SMA 200 | $3.37 | |
| SMA 200 vs Price | -28.67% | |
| SMA 50 | $4.35 | |
| SMA 50 vs Price | -7.95% | |
| Beta | 2.03 | |
| ATR | $0.36 | |
| 14-Day RSI | 56.46 | |
| 10-Day Volatility | 73.92% | |
| 1-Year Volatility | 197.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$1.16 | |
| Gross Profit | -$15.49M | |
| - | ||
| Operating Profit | -$271.47M | |
| - | ||
| Net Income | -$266.76M | |
| - | ||
| EBITDA | -$255.98M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.38 | |
| Current Ratio | 3.54 | |
| Quick Ratio | 3.54 | |
| - | ||
| - | ||
| Altman Z-Score | -2.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 6.45 | |
| EV/EBITDA | -6.71 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $250.50M | |
| Cash & Equivalents | $127.57M | |
| Total Assets | $501.02M | |
| Current Assets | $160.81M | |
| Total Liabilities | $250.52M | |
| Current Liabilities | $45.43M | |
| Total Debt | $94.20M | |
| Short Term Debt | $12.53M | |
| Accounts Payable | $5.21M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $266.76M | |
| Operating Expenses | $255.98M | |
| Cost Of Goods Sold | $15.49M | |
| SG&A | $0.00 | |
| D&A | $25.17M | |
| Interest Expense | $0.00 | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$223.15M | |
| CFI | $17.45M | |
| CFF | $199.75M | |
| Capex | $33.43M | |
| Free Cash Flow | -$256.58M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Citizens | → | |
| Wedbush | ||
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Citizens Capital Markets | → | |
| Jefferies | ||
| TD Cowen | → |
Analyst sentiment
Institutional ownership
Screeners with SANA
Data Sources & References
- SANA Official Website www.sana.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770121/000119312525269569/0001193125-25-269569-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770121/000095017025040254/0000950170-25-040254-index.htm
- SANA Profile on Yahoo Finance finance.yahoo.com/quote/SANA
- SANA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sana
FAQ
What is the ticker symbol for Sana Biotechnology, Inc.?
The ticker symbol for Sana Biotechnology, Inc. is NASDAQ:SANA
Does Sana Biotechnology, Inc. pay dividends?
No, Sana Biotechnology, Inc. does not pay dividends
What sector is Sana Biotechnology, Inc. in?
Sana Biotechnology, Inc. is in the Healthcare sector
What industry is Sana Biotechnology, Inc. in?
Sana Biotechnology, Inc. is in the Biotechnology industry
What country is Sana Biotechnology, Inc. based in?
Sana Biotechnology, Inc. is headquartered in United States
When did Sana Biotechnology, Inc. go public?
Sana Biotechnology, Inc. initial public offering (IPO) was on February 4, 2021
Is Sana Biotechnology, Inc. in the S&P 500?
No, Sana Biotechnology, Inc. is not included in the S&P 500 index
Is Sana Biotechnology, Inc. in the NASDAQ 100?
No, Sana Biotechnology, Inc. is not included in the NASDAQ 100 index
Is Sana Biotechnology, Inc. in the Dow Jones?
No, Sana Biotechnology, Inc. is not included in the Dow Jones index
When was Sana Biotechnology, Inc. last earnings report?
Sana Biotechnology, Inc.'s most recent earnings report was on November 6, 2025
When does Sana Biotechnology, Inc. report earnings?
The next expected earnings date for Sana Biotechnology, Inc. is March 16, 2026